Recombinant human granulocyte-macrophage colony-stimulating factor plus the beam regimen instead of autologous bone marrow transplantation

Lancet. 1989 Jun 24;1(8652):1460. doi: 10.1016/s0140-6736(89)90176-1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Marrow Transplantation
  • Carmustine / administration & dosage
  • Colony-Stimulating Factors / administration & dosage*
  • Cytarabine / administration & dosage
  • Granulocyte Colony-Stimulating Factor
  • Humans
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Male
  • Melphalan / administration & dosage
  • Middle Aged
  • Podophyllotoxin / administration & dosage
  • Recombinant Proteins / administration & dosage

Substances

  • Colony-Stimulating Factors
  • Recombinant Proteins
  • Cytarabine
  • Granulocyte Colony-Stimulating Factor
  • Podophyllotoxin
  • Melphalan
  • Carmustine

Supplementary concepts

  • BEAM protocol